Refine by
Disease Development Equipment & Supplies
76 equipment items found
Manufactured by:Akoya Biosciences based inMarlborough, MASSACHUSETTS (USA)
Characterizing the complexities of the tissue microenvironment is a critical step towards understanding molecular and cellular mechanisms associated with disease development, differentiation, and response. The PhenoCycler®-Fusion allows spatial phenotyping of millions of cells at unprecedented scale and speed. Mapping millions of cells and their ...
by:Alexion Pharmaceuticals, Inc. based inBoston, MASSACHUSETTS (USA)
People with rare diseases often wait years to receive a proper diagnosis and many never receive one at all. RARE ANSWERS™ is a system of innovative and sustainable tools designed to help shorten the diagnostic journey and time to initiating treatment of children with a rare disease. Developed in collaboration with leading children’s ...
Manufactured by:Moon (Guangzhou) Biotech Co.,Ltd based inHuangpu District, CHINA
From tremendous microbiome resources to precision microbe-based drug. Human microbiome is recognized as the central hub of human health and disease development and harbors tremendous microbe-based drugs for improving human health and treating diseases. MoonBiotech is moving to a clinical-stage biotech company focused on the ...
Manufactured by:GenSol Diagnostics based inClayton, GEORGIA (US) (USA)
The A Locus (agouti series) interacts closely with the E, K, and B Loci that can lead to a dog’s overall coat color and pattern. A Locus mutations are only expressed if the dog is “Clear” or “Carrier” at the E locus and “Clear” at the K-KB locus. There are three potential mutations at the A Locus that can each have a different effect on coat color. The ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
AD1503 is an innovative project to develop a disease modifying treatment for prodromal and mild Alzheimer’s disease. ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
AD1502 is an innovative project to develop a disease modifying treatment for prodromal and mild Alzheimer’s disease. ...
Manufactured by:LevMed by KHS Medical BV based inWaalwijk, NETHERLANDS
12-lead Diagnostic ECG: ANYTIME, ANYWHERE, BY ANYONE. At LevMed we bring 12-lead diagnostic hospital grade ECG assessments at anytime to anyone, anywhere in the ...
Manufactured by:Brooklyn ImmunoTherapeutics (BTX) based inSan Diego, CALIFORNIA (USA)
The foundational technology of synthetic mRNA, precise gene-editing machinery, and non-viral delivery also enable the development of genetic medicines with curative potential for multiple disease states. Brooklyn is developing products designed to edit a patient’s genome inside their body and address diseases with ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
To hinder or inhibit the function of proteins that cause disease, many pharmaceutical companies develop drugs called inhibitors. Each of the 20,000 proteins in the human body has its own unique functions. Depending on the function of the protein, it can be classified into enzyme proteins, ion channel proteins, transport proteins, defense proteins, and structural ...
Manufactured by:Inovarion based inParis, FRANCE
Sensitized to the ethics of animal experimentation and to the respect of the 3Rs principles (replacement, reduction, refinement), Inovarion’s experts can assist you in your experiments requiring the use of animal ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
Mutations in the methylenetetrahydrofolate reductase (MTHFR) gene are associated with decreased enzyme activity, which leads to hyperhomocysteinemia and toxic side effects of methotrexate therapy. ViennaLab assays identify patients predisposed to develop cardiovascular diseases or intolerance to ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
Manufactured by:PolyVascular based inHouston, TEXAS (USA)
Congenital heart disease (CHD) is the most common birth defect and number one cause of infant mortality in the developed world. Twice as many children die from CHD than all childhood cancers combined. Our aim is to transform the care of children with congenital heart disease by developing an entirely new generation of ...
Manufactured by:Invitae Corporation based inSan Francisco, CALIFORNIA (USA)
Like wearing sunscreen or getting your blood pressure checked at the doctor, genetic testing is another important tool to help manage your health and lifestyle. Your genes can give you clues into your risk of developing disease and—if it turns out that you have an increased risk of a condition—there are steps you can take to help you stay healthy. ...
Manufactured by:Trailhead Biosystems Inc. based inBeachwood, OHIO (USA)
We are currently developing a novel protocol that will use only small molecules to make human medium spiny neurons from human (non-embryo) induced pluripotent stem cells (iPSCs). We will use our medium spiny neurons as the foundation for a cell transplantation therapy for treating Huntington’s Disease, which we are ...
Manufactured by:GenSol Diagnostics based inClayton, GEORGIA (US) (USA)
Laryngeal paralysis (LP) is a genetic disorder that results in breathing difficulties which can be made worse by physical activity and may lead to suffocation in severe cases. The condition may require surgery to alleviate breathing difficulties. Symptoms of the disease can include a respiratory murmur, wheezing, reduced tolerance for exercise, voice impairment, difficulty ...
Manufactured by:RedHill Biopharma Ltd. based inTel-Aviv, ISRAEL
RHB-104 is a potentially groundbreaking, proprietary investigational drug in oral capsule formulation, with potent intracellular, antimycobacterial and anti-inflammatory ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso2 is a preclinical program targeting Crohn’s disease. It aims to develop Christensenella gut bacteria as a safe, efficient and groundbreaking oral biotherapy. YSOPIA has identified a lead candidate to relieve Crohn’s disease associated symptoms and slow down disease progression. ...